Stemline Therapeutics 3.317M share IPO priced at $10.00 Aegis acted as lead book running manager for the offering. The deal size was increased to 3.317M shares from 2.275M shares and priced at the bottom of the $10.00-$12.00 range.
News For STML From The Last 14 Days
Check below for free stories on STML the last two weeks.